DE2462312A1 - Arzneimittel zur behandlung von migraene-erkrankungen - Google Patents

Arzneimittel zur behandlung von migraene-erkrankungen

Info

Publication number
DE2462312A1
DE2462312A1 DE19742462312 DE2462312A DE2462312A1 DE 2462312 A1 DE2462312 A1 DE 2462312A1 DE 19742462312 DE19742462312 DE 19742462312 DE 2462312 A DE2462312 A DE 2462312A DE 2462312 A1 DE2462312 A1 DE 2462312A1
Authority
DE
Germany
Prior art keywords
lithium
caffeine
migraine
contg
ergotamine tartrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19742462312
Other languages
English (en)
Inventor
Hans A Dr Med Nieper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PERMICUTAN-KG DR. EULER, 4790 PADERBORN, DE
Original Assignee
NADROL CHEMIE PHARMA KEIZER KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NADROL CHEMIE PHARMA KEIZER KG filed Critical NADROL CHEMIE PHARMA KEIZER KG
Priority to DE19742462312 priority Critical patent/DE2462312A1/de
Publication of DE2462312A1 publication Critical patent/DE2462312A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
DE19742462312 1974-03-04 1974-03-04 Arzneimittel zur behandlung von migraene-erkrankungen Withdrawn DE2462312A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19742462312 DE2462312A1 (de) 1974-03-04 1974-03-04 Arzneimittel zur behandlung von migraene-erkrankungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742462312 DE2462312A1 (de) 1974-03-04 1974-03-04 Arzneimittel zur behandlung von migraene-erkrankungen

Publications (1)

Publication Number Publication Date
DE2462312A1 true DE2462312A1 (de) 1976-10-14

Family

ID=5934956

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742462312 Withdrawn DE2462312A1 (de) 1974-03-04 1974-03-04 Arzneimittel zur behandlung von migraene-erkrankungen

Country Status (1)

Country Link
DE (1) DE2462312A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003049730A1 (en) * 2001-12-13 2003-06-19 Magral Limited Treatment of statin side effects using uridine derivatives
EP1343488A1 (de) * 2000-11-29 2003-09-17 Centre For Molecular Biology And Medicine Behandlung der nebenwirkungen von statinen

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1343488A1 (de) * 2000-11-29 2003-09-17 Centre For Molecular Biology And Medicine Behandlung der nebenwirkungen von statinen
JP2004531468A (ja) * 2000-11-29 2004-10-14 マグラル・リミテッド スタチン副作用の処置
EP1343488A4 (de) * 2000-11-29 2005-05-04 Magral Ltd Behandlung der nebenwirkungen von statinen
WO2003049730A1 (en) * 2001-12-13 2003-06-19 Magral Limited Treatment of statin side effects using uridine derivatives
JP4781629B2 (ja) * 2001-12-13 2011-09-28 マグラル・リミテッド ウリジン誘導体を用いるスタチンの副作用の処置

Similar Documents

Publication Publication Date Title
ES425158A1 (es) PROCEDURE FOR OBTAINING DENTIFY COMPOSITIONS.
JPS51126586A (en) Device for stopping the spindle of turret type machining center in fix ed phase
ES412813A1 (es) Un procedimiento de preparacion de derivados de 1,2-benzoi-soxazol 3-sustituidos.
DE2462312A1 (de) Arzneimittel zur behandlung von migraene-erkrankungen
DE2410181B2 (de) Arzneimittel zur oralen lithium- behandlung
FR2255883A1 (en) Clofibric acid-vitamin B6 compsns. - with synergistic hypocholesterolaemic and normolipaemic activity
YU33762B (en) Process for the reduction of ammonium ions in a liquid, moving in a circular current in a cyclic process for the manufacture and treatment of solutions of hydroxylammonium salts
DK146200C (da) Fremgangsmaade til energibesparende oparbejdning af spildevand, der stammer fra regenereringen af de til behandling af sukkersafter anvendte ionbytter- og adsorptionsharpikser
FR2155927A1 (en) 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity
JPS5328092A (en) Treating method for aqueous solution containing ininorganic anion
FR2073427A1 (en) 4-methyl-5-ethyl-n-heterocyclic thiazoles - with antianoxic activity
JPS5274568A (en) Treating of exhaust liquid containing nutritious salts having nitrogen
CH505102A (de) Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
ES416766A1 (es) Un procedimiento para la preparacion de (3 - trifluormetil-fenoxi) - (4 - clorofenil) acetato de 2 - acetamidoetilo.
FR2260995A1 (en) Benzimidazole-contg. medicaments - for treating non-malignant gastroduodenal disorders, esp. ulcers and hypersecretion
SU510242A1 (ru) Корректор дл лечени парезов лицевого нерва
SU523871A1 (ru) Способ получени карбоната кальци
GB1324937A (en) Process for the preparation of a calcium salt solution with calcium effect pharmaceutical preparation having calcium effect as well as a method for treating calcium deficiency
FR2267089A1 (en) 2-(3-Pyridyl)-4-carboxy-thiazolidine compns. - with hypolipaemic, hypocholesterolaemic and antiinflammatory activity
ES402774A1 (es) Un procedimiento para preparar un compuesto de i-metil-4- fenilpiridinio.
FR2125219A1 (en) Lithium undecylenate for topical fungal disorders
JPS5335386A (en) Production of semiconductor device
CA933362A (en) Method for the treatment of irradiated fuel elements
JPS5256076A (en) Process of adsorption or tion exchange of moving bed type and its equi pment
FR2166349A1 (en) Difeu alkaloids - for treating diarrhoea, peptic ulcer anorexia, as a diuretic, as a sclerosing agent

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: PERMICUTAN-KG DR. EULER, 4790 PADERBORN, DE

8139 Disposal/non-payment of the annual fee